Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Single Centre Study to Assess the Safety and Efficacy of Movicol in the Treatment of Faecal Impaction in Children Followed by a Double Blind, Randomised Phase to Compare the Safety and Efficacy of Movicol and Lactulose for Maintenance Therapy

NCT00403858 is registered in ClinicalTrials.gov with Norgine as lead sponsor.

NCT NCT00403858
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00403858 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Single Centre Study to Assess the Safety and Efficacy of Movicol in the Treatment of Faecal Impaction in Children Followed by a Double Blind, Randomised Phase to Compare the Safety and Efficacy of Movicol and Lactulose for Maintenance Therapy
Lead sponsor
Norgine
Phase
Phase 2
Overall status
Completed
Start date
October 31, 2000
Completion date
April 30, 2002
Enrollment
60
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

feces, impacted